KentuckyAN ACT relating to buprenorphine products.
What it does
Create a new section of KRS Chapter 311 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed physician to meet the treatment needs of a patient; require the Kentucky Board of Medical Licensure to promulgate administrative regulations to implement the requirement; create a new section of KRS Chapter 314 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed advanced practice registered nurse meet the treatment needs of a patient; require the Kentucky Board of Nursing to promulgate administrative regulations to implement the requirement.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Mar 5returned to Health Services (H)Latest
- Mar 51st readingMinor
- Mar 5taken from Health Services (H)
- Feb 26to Health Services (H)Minor
- Feb 19to Committee on Committees (H)Minor
- Feb 19introduced in HouseIntroduced